title: Vaccinia virus complement control protein ameliorates hyperacute xenorejection by inhibiting xenoantibody binding.
authors.affiliation: Department of Microbiology, University of Louisville School of Medicine, Louisville, Kentucky 40202, USA.
authors.forename: J B
authors.initials: JB
authors.lastname: Anderson
authors.forename: S A
authors.initials: SA
authors.lastname: Smith
authors.forename: R
authors.initials: R
authors.lastname: van Wijk
authors.forename: S
authors.initials: S
authors.lastname: Chien
authors.forename: G J
authors.initials: GJ
authors.lastname: Kotwal
mesh_terms: D000818:Animals; D000910:Antibodies, Heterophile / Q000097:blood*; D006084:Graft Rejection / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D008297:Male; D051379:Mice; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000627:therapeutic use; D014183:Transplantation, Heterologous / Q000276:immunology*; D014764:Viral Proteins / Q000627:therapeutic use*
chemical_list: D000910:Antibodies, Heterophile; D011994:Recombinant Proteins; D014764:Viral Proteins; C066459:complement-control protein, Vaccinia virus